Literature DB >> 17612702

Does folate therapy reduce the risk of coronary restenosis?

E S van Hattum1, P A Doevendans, F L Moll.   

Abstract

BACKGROUND.: A high homocysteine level is associated with an increased risk of ischaemic heart disease. Folate therapy has shown to reduce the homocysteine blood level, but does it decrease the risk of coronary restenosis in patients with coronary arterial disease? METHODS.: A systematic online literature search followed by a critical appraisal resulted in three suitable articles to provide an evidence-based evaluation of this clinical query. RESULTS.: The rate of coronary restenosis was reduced after folate therapy, except in patients who have had coronary stenting. An adverse effect of folate therapy on in-stent coronary restenosis was observed. CONCLUSION.: The effects of folate therapy on the rate of coronary restenosis after balloon angioplasty are contradicting. Until more clinical research has been preformed we recommend a conservative attitude towards folate therapy. (Neth Heart J 2007;15:12-5.).

Entities:  

Year:  2007        PMID: 17612702      PMCID: PMC1847724          DOI: 10.1007/bf03086052

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  9 in total

1.  Secondary prevention with folic acid: results of the Goes extension study.

Authors:  A Liem; G H Reynierse-Buitenwerf; A H Zwinderman; J W Jukema; D J van Veldhuisen
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

2.  Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.

Authors:  G Schnyder; M Roffi; R Pin; Y Flammer; H Lange; F R Eberli; B Meier; Z G Turi; O M Hess
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

3.  Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finnish cohorts of the Seven Countries Study.

Authors:  M Tervahauta; J Pekkanen; A Nissinen
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

Review 4.  Homocysteine and atherothrombosis.

Authors:  G N Welch; J Loscalzo
Journal:  N Engl J Med       Date:  1998-04-09       Impact factor: 91.245

5.  Heart attacks and homocysteine.

Authors:  I Graham; R Meleady
Journal:  BMJ       Date:  1996-12-07

6.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1998-03-21

7.  Effect of folic acid fortification of food on homocysteine-related mortality.

Authors:  Jeffrey L Anderson; Kurt R Jensen; John F Carlquist; Tami L Bair; Benjamin D Horne; Joseph B Muhlestein
Journal:  Am J Med       Date:  2004-02-01       Impact factor: 4.965

8.  Folate therapy and in-stent restenosis after coronary stenting.

Authors:  Helmut Lange; Harry Suryapranata; Giuseppe De Luca; Caspar Börner; Joep Dille; Klaus Kallmayer; M Noor Pasalary; Eberhard Scherer; Jan-Henk E Dambrink
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

  9 in total
  1 in total

1.  The predictive value of vitamin B12 concentrations and hyperhomocysteinaemia for cardiovascular disease.

Authors:  M G H van Oijen; R J F Laheij; J B M J Jansen; F W A Verheugt
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.